Viewing Study NCT06161558


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-05-13 @ 6:55 AM
Study NCT ID: NCT06161558
Status: WITHDRAWN
Last Update Posted: 2025-07-16
First Post: 2023-12-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kinase Inhibitor View
None Combination View
None Pharmacodynamic View
None TKI View